FDA Awards Breakthrough Designation to Pi-Cardia’s ShortCut Catheter
ShortCut is the first dedicated leaflet modification device to enable TAVR in patients at risk of coronary obstruction, according to Pi-Cardia.
Read MoreShortCut is the first dedicated leaflet modification device to enable TAVR in patients at risk of coronary obstruction, according to Pi-Cardia.
Read MoreThe recent surge can trigger cardiovascular complications from fever, dehydration, and increased inflammation, and Mount Sinai doctors are seeing a rise in these cases in all age groups, including patients in their 20s.
Read MoreInvestigators say there was no statistically significant difference between the effectiveness of the two methods, with each patient group experiencing a more than 50% reduction in the severity of depressive symptoms.
Read MoreBreathing through the nose leads to several benefits, including lower blood pressure and other factors that could predict heart disease risk.
Read MoreDistributing these devices could allow healthcare workers, without specialized medical degrees, to carry technology that could detect rheumatic heart disease in regions where it remains endemic, according to the researchers.
Read More